APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Precision Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Personalized Precision Medicine Market Outlook and Growth Opportunities 2026

3 March 2026208 pages

Choose your research edition.

Industry ResearchPersonalized Precision Medicine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Precision Medicine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Personalized Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Precision Medicine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Personalized Precision Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Personalized Precision Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Personalized Precision Medicine market include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Personalized Precision Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Personalized Precision Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Personalized Precision Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Personalized Precision Medicine market.

Personalized Precision Medicine Segment by Company

Agilent Technologies

Biogen

Johnson & Johnson

Boai NKY Pharmaceuticals Ltd.

Novartis

Pfizer

Roche

AstraZeneca

Sanofi

Amgen

Takeda Pharmaceutical

Merck

Eli Lilly

IQVIA

AbbVie

Parexel

Personalized Precision Medicine Segment by Type

Gene Therapy

Personalized Medication

Health Management

Others

Personalized Precision Medicine Segment by Application

Tumors and Cancer

Cardiovascular Diseases

Genetic Disease

Autoimmune Disease

Others

Personalized Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Personalized Precision Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Personalized Precision Medicine key companies, revenue, market share, and recent developments.

3. To split the Personalized Precision Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Personalized Precision Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Personalized Precision Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Personalized Precision Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Precision Medicine industry.

Chapter 3: Detailed analysis of Personalized Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Personalized Precision Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Personalized Precision Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Personalized Precision Medicine Industry Trends Table 2. Personalized Precision Medicine Industry Drivers Table 3. Personalized Precision Medicine Industry Opportunities and Challenges Table 4. Personalized Precision Medicine Industry Restraints Table 5. Global Personalized Precision Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Personalized Precision Medicine Revenue Share by Company (2021-2026) Table 7. Global Personalized Precision Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Personalized Precision Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Personalized Precision Medicine Company, Product Type & Application Table 10. Global Personalized Precision Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Personalized Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Therapy Table 15. Significant Companies of Personalized Medication Table 16. Significant Companies of Health Management Table 17. Significant Companies of Others Table 18. Global Personalized Precision Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Personalized Precision Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Personalized Precision Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Personalized Precision Medicine Sales Value Share by Type (2021-2026) Table 22. Global Personalized Precision Medicine Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Tumors and Cancer Table 24. Significant Companies of Cardiovascular Diseases Table 25. Significant Companies of Genetic Disease Table 26. Significant Companies of Autoimmune Disease Table 27. Significant Companies of Others Table 28. Global Personalized Precision Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Personalized Precision Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Personalized Precision Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Personalized Precision Medicine Sales Value Share by Application (2021-2026) Table 32. Global Personalized Precision Medicine Sales Value Share by Application (2027-2032) Table 33. Global Personalized Precision Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Personalized Precision Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Personalized Precision Medicine Sales Value Share by Region (2021-2026) Table 36. Global Personalized Precision Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Personalized Precision Medicine Sales Value Share by Region (2027-2032) Table 38. Global Personalized Precision Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Personalized Precision Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Personalized Precision Medicine Sales Value Market Share by Country (2021-2026) Table 41. Global Personalized Precision Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Personalized Precision Medicine Sales Value Market Share by Country (2027-2032) Table 43. Agilent Technologies Company Information Table 44. Agilent Technologies Business Overview Table 45. Agilent Technologies Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Agilent Technologies Personalized Precision Medicine Product Portfolio Table 47. Agilent Technologies Recent Development Table 48. Biogen Company Information Table 49. Biogen Business Overview Table 50. Biogen Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Biogen Personalized Precision Medicine Product Portfolio Table 52. Biogen Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Personalized Precision Medicine Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Boai NKY Pharmaceuticals Ltd. Company Information Table 59. Boai NKY Pharmaceuticals Ltd. Business Overview Table 60. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio Table 62. Boai NKY Pharmaceuticals Ltd. Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Novartis Personalized Precision Medicine Product Portfolio Table 67. Novartis Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pfizer Personalized Precision Medicine Product Portfolio Table 72. Pfizer Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Roche Personalized Precision Medicine Product Portfolio Table 77. Roche Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. AstraZeneca Personalized Precision Medicine Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanofi Personalized Precision Medicine Product Portfolio Table 87. Sanofi Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Personalized Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Amgen Personalized Precision Medicine Product Portfolio Table 92. Amgen Recent Development Table 93. Takeda Pharmaceutical Company Information Table 94. Takeda Pharmaceutical Business Overview Table 95. Takeda Pharmaceutical Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio Table 97. Takeda Pharmaceutical Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Merck Personalized Precision Medicine Product Portfolio Table 102. Merck Recent Development Table 103. Eli Lilly Company Information Table 104. Eli Lilly Business Overview Table 105. Eli Lilly Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Eli Lilly Personalized Precision Medicine Product Portfolio Table 107. Eli Lilly Recent Development Table 108. IQVIA Company Information Table 109. IQVIA Business Overview Table 110. IQVIA Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. IQVIA Personalized Precision Medicine Product Portfolio Table 112. IQVIA Recent Development Table 113. AbbVie Company Information Table 114. AbbVie Business Overview Table 115. AbbVie Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. AbbVie Personalized Precision Medicine Product Portfolio Table 117. AbbVie Recent Development Table 118. Parexel Company Information Table 119. Parexel Business Overview Table 120. Parexel Personalized Precision Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Parexel Personalized Precision Medicine Product Portfolio Table 122. Parexel Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Personalized Precision Medicine Product Image Figure 2. Global Personalized Precision Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Personalized Precision Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Therapy Image Figure 8. Personalized Medication Image Figure 9. Health Management Image Figure 10. Others Image Figure 11. Global Personalized Precision Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Personalized Precision Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Personalized Precision Medicine Sales Value Share by Type (2021-2032) Figure 14. Tumors and Cancer Image Figure 15. Cardiovascular Diseases Image Figure 16. Genetic Disease Image Figure 17. Autoimmune Disease Image Figure 18. Others Image Figure 19. Global Personalized Precision Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Personalized Precision Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Personalized Precision Medicine Sales Value Share by Application (2021-2032) Figure 22. Global Personalized Precision Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Personalized Precision Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Personalized Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 25. North America Personalized Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Personalized Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Personalized Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Personalized Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Personalized Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Personalized Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 31. South America Personalized Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Personalized Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Personalized Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Personalized Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Personalized Medication
  • Health Management
  • Others
Applications
  • Tumors and Cancer
  • Cardiovascular Diseases
  • Genetic Disease
  • Autoimmune Disease
  • Others
Companies covered
  • Agilent Technologies
  • Biogen
  • Johnson & Johnson
  • Boai NKY Pharmaceuticals Ltd.
  • Novartis
  • Pfizer
  • Roche
  • AstraZeneca
  • Sanofi
  • Amgen
  • Takeda Pharmaceutical
  • Merck
  • Eli Lilly
  • IQVIA
  • AbbVie
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Personalized Precision Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Personalized Precision Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Personalized Precision Medicine Market Dynamics
  1. 2.1 Personalized Precision Medicine Industry Trends
  2. 2.2 Personalized Precision Medicine Industry Drivers
  3. 2.3 Personalized Precision Medicine Industry Opportunities and Challenges
  4. 2.4 Personalized Precision Medicine Industry Restraints
3 Personalized Precision Medicine Market by Company
  1. 3.1 Global Personalized Precision Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Personalized Precision Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Personalized Precision Medicine Company Ranking (2024-2026)
  4. 3.4 Global Personalized Precision Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Personalized Precision Medicine Company Product Type and Application
  6. 3.6 Global Personalized Precision Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Personalized Precision Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Personalized Precision Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Personalized Precision Medicine Market by Type
  1. 4.1 Personalized Precision Medicine Type Introduction
  2. 4.1.1 Gene Therapy
  3. 4.1.2 Personalized Medication
  4. 4.1.3 Health Management
  5. 4.1.4 Others
  6. 4.2 Global Personalized Precision Medicine Sales Value by Type
  7. 4.2.1 Global Personalized Precision Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Personalized Precision Medicine Sales Value by Type (2021-2032)
  9. 4.2.3 Global Personalized Precision Medicine Sales Value Share by Type (2021-2032)
5 Personalized Precision Medicine Market by Application
  1. 5.1 Personalized Precision Medicine Application Introduction
  2. 5.1.1 Tumors and Cancer
  3. 5.1.2 Cardiovascular Diseases
  4. 5.1.3 Genetic Disease
  5. 5.1.4 Autoimmune Disease
  6. 5.1.5 Others
  7. 5.2 Global Personalized Precision Medicine Sales Value by Application
  8. 5.2.1 Global Personalized Precision Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Personalized Precision Medicine Sales Value by Application (2021-2032)
  10. 5.2.3 Global Personalized Precision Medicine Sales Value Share by Application (2021-2032)
6 Personalized Precision Medicine Regional Value Analysis
  1. 6.1 Global Personalized Precision Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Personalized Precision Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Personalized Precision Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Personalized Precision Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Personalized Precision Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Personalized Precision Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Personalized Precision Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Personalized Precision Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Personalized Precision Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Personalized Precision Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Personalized Precision Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Personalized Precision Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Personalized Precision Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Personalized Precision Medicine Sales Value Share by Country, 2025 VS 2032
7 Personalized Precision Medicine Country-level Value Analysis
  1. 7.1 Global Personalized Precision Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Personalized Precision Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Personalized Precision Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Personalized Precision Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Personalized Precision Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Personalized Precision Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Personalized Precision Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent Technologies
  2. 8.1.1 Agilent Technologies Company Information
  3. 8.1.2 Agilent Technologies Business Overview
  4. 8.1.3 Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Technologies Personalized Precision Medicine Product Portfolio
  6. 8.1.5 Agilent Technologies Recent Developments
  7. 8.2 Biogen
  8. 8.2.1 Biogen Company Information
  9. 8.2.2 Biogen Business Overview
  10. 8.2.3 Biogen Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biogen Personalized Precision Medicine Product Portfolio
  12. 8.2.5 Biogen Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Personalized Precision Medicine Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Boai NKY Pharmaceuticals Ltd.
  20. 8.4.1 Boai NKY Pharmaceuticals Ltd. Company Information
  21. 8.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
  22. 8.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio
  24. 8.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Personalized Precision Medicine Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Personalized Precision Medicine Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Personalized Precision Medicine Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Personalized Precision Medicine Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Personalized Precision Medicine Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Amgen
  56. 8.10.1 Amgen Company Information
  57. 8.10.2 Amgen Business Overview
  58. 8.10.3 Amgen Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amgen Personalized Precision Medicine Product Portfolio
  60. 8.10.5 Amgen Recent Developments
  61. 8.11 Takeda Pharmaceutical
  62. 8.11.1 Takeda Pharmaceutical Company Information
  63. 8.11.2 Takeda Pharmaceutical Business Overview
  64. 8.11.3 Takeda Pharmaceutical Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio
  66. 8.11.5 Takeda Pharmaceutical Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Personalized Precision Medicine Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Eli Lilly
  74. 8.13.1 Eli Lilly Company Information
  75. 8.13.2 Eli Lilly Business Overview
  76. 8.13.3 Eli Lilly Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Eli Lilly Personalized Precision Medicine Product Portfolio
  78. 8.13.5 Eli Lilly Recent Developments
  79. 8.14 IQVIA
  80. 8.14.1 IQVIA Company Information
  81. 8.14.2 IQVIA Business Overview
  82. 8.14.3 IQVIA Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  83. 8.14.4 IQVIA Personalized Precision Medicine Product Portfolio
  84. 8.14.5 IQVIA Recent Developments
  85. 8.15 AbbVie
  86. 8.15.1 AbbVie Company Information
  87. 8.15.2 AbbVie Business Overview
  88. 8.15.3 AbbVie Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AbbVie Personalized Precision Medicine Product Portfolio
  90. 8.15.5 AbbVie Recent Developments
  91. 8.16 Parexel
  92. 8.16.1 Parexel Company Information
  93. 8.16.2 Parexel Business Overview
  94. 8.16.3 Parexel Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Parexel Personalized Precision Medicine Product Portfolio
  96. 8.16.5 Parexel Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst